
Dhampur Bio Organics (DBOL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
5.3B
Gross Profit
801.5M
15.25%
Operating Income
-129.0M
-2.45%
Net Income
-220.0M
-4.19%
EPS (Diluted)
₹-3.31
Balance Sheet Metrics
Total Assets
24.0B
Total Liabilities
13.9B
Shareholders Equity
10.1B
Debt to Equity
1.37
Cash Flow Metrics
Revenue & Profitability Trend
Dhampur Bio Organics Income Statement From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue | 18.4B | 18.4B | 23.7B | 15.3B |
Cost of Goods Sold | 14.9B | 14.7B | 19.2B | 11.9B |
Gross Profit | 3.6B | 3.6B | 4.5B | 3.4B |
Gross Margin % | 19.3% | 19.8% | 19.1% | 22.1% |
Operating Expenses | ||||
Research & Development | - | - | - | - |
Selling, General & Administrative | 439.0M | 642.4M | 944.6M | 499.8M |
Other Operating Expenses | 910.1M | 820.0M | 739.0M | 630.0M |
Total Operating Expenses | 1.3B | 1.5B | 1.7B | 1.1B |
Operating Income | 820.3M | 924.4M | 1.7B | 1.6B |
Operating Margin % | 4.5% | 5.0% | 7.3% | 10.2% |
Non-Operating Items | ||||
Interest Income | 15.9M | 23.1M | 4.8M | 5.2M |
Interest Expense | 645.5M | 433.6M | 380.8M | 294.2M |
Other Non-Operating Income | - | - | - | - |
Pre-tax Income | 157.1M | 654.9M | 1.3B | 1.3B |
Income Tax | 10.2M | 190.0M | 236.7M | 270.8M |
Effective Tax Rate % | 6.5% | 29.0% | 17.6% | 20.9% |
Net Income | 146.9M | 464.9M | 1.1B | 1.0B |
Net Margin % | 0.8% | 2.5% | 4.7% | 6.7% |
Key Metrics | ||||
EBITDA | 1.4B | 1.4B | 2.1B | 1.9B |
EPS (Basic) | ₹2.21 | ₹7.00 | ₹16.74 | ₹15.41 |
EPS (Diluted) | ₹2.21 | ₹7.00 | ₹16.74 | ₹15.41 |
Basic Shares Outstanding | 66387590 | 66387590 | 66387590 | 66387590 |
Diluted Shares Outstanding | 66387590 | 66387590 | 66387590 | 66387590 |
Income Statement Trend
Dhampur Bio Organics Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 88.8M | 59.9M | 1.0B | 229.8M | 138.7M |
Short-term Investments | 236.8M | 234.0M | 970.0M | - | - |
Accounts Receivable | 548.0M | 875.3M | 1.5B | 1.1B | 1.1B |
Inventory | 10.9B | 10.8B | 8.2B | 10.6B | 7.2B |
Other Current Assets | 70.1M | 91.0M | 69.3M | 30.4M | 477.6M |
Total Current Assets | 12.3B | 12.5B | 11.2B | 12.2B | 9.0B |
Non-Current Assets | |||||
Property, Plant & Equipment | 120.4M | 92.0M | 96.7M | 82.2M | 75.9M |
Goodwill | 1.6M | 0 | 0 | 0 | 0 |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 6.1M | 5.8M | 5.5M | 5.1M | 4.6M |
Total Non-Current Assets | 11.7B | 10.6B | 9.5B | 7.8B | 6.5B |
Total Assets | 24.0B | 23.1B | 20.8B | 20.0B | 15.5B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.2B | 1.4B | 1.6B | 1.7B | 3.0B |
Short-term Debt | 9.2B | 8.7B | 6.4B | 7.2B | 3.0B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 168.6M | 4.4M | -10.2M | 22.8M | 31.2M |
Total Current Liabilities | 10.8B | 10.5B | 8.6B | 9.6B | 6.2B |
Non-Current Liabilities | |||||
Long-term Debt | 2.4B | 1.8B | 1.7B | 1.1B | 1.0B |
Deferred Tax Liabilities | 396.7M | 425.0M | 349.0M | 339.9M | 307.3M |
Other Non-Current Liabilities | -6.2M | 600.0K | 600.0K | 12.6M | 54.5M |
Total Non-Current Liabilities | 3.0B | 2.5B | 2.3B | 1.7B | 1.6B |
Total Liabilities | 13.9B | 13.0B | 10.9B | 11.2B | 7.8B |
Equity | |||||
Common Stock | 663.9M | 663.9M | 663.9M | 663.9M | 663.9M |
Retained Earnings | 2.3B | 2.4B | 2.1B | 1.0B | -100.0K |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 10.1B | 10.1B | 9.9B | 8.8B | 7.7B |
Key Metrics | |||||
Total Debt | 11.6B | 10.6B | 8.1B | 8.3B | 4.0B |
Working Capital | 1.5B | 2.0B | 2.7B | 2.7B | 2.8B |
Balance Sheet Composition
Dhampur Bio Organics Cash Flow Statement From 2022 to 2025
Metric | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Operating Activities | ||||
Net Income | 174.7M | 654.9M | 1.3B | 1.3B |
Depreciation & Amortization | - | - | - | - |
Stock-Based Compensation | - | - | - | - |
Working Capital Changes | 260.3M | -2.0B | 1.8B | -2.9B |
Operating Cash Flow | 1.1B | -911.3M | 3.5B | -1.2B |
Investing Activities | ||||
Capital Expenditures | -1.4B | -1.4B | -2.1B | -1.4B |
Acquisitions | -100.0K | - | -166.6M | 0 |
Investment Purchases | - | -240.7M | -16.3M | -12.2M |
Investment Sales | - | - | 0 | 1.8M |
Investing Cash Flow | -1.4B | -1.7B | -2.3B | -1.4B |
Financing Activities | ||||
Share Repurchases | - | - | - | - |
Dividends Paid | -167.2M | -231.2M | - | - |
Debt Issuance | 1.3B | 723.3M | 1.4B | 842.5M |
Debt Repayment | -642.6M | -783.0M | -634.4M | -507.2M |
Financing Cash Flow | 887.8M | 2.2B | -278.9M | 4.3B |
Free Cash Flow | -161.7M | -2.7B | 1.4B | -3.9B |
Net Change in Cash | 531.5M | -399.3M | 953.5M | 1.6B |
Cash Flow Trend
Dhampur Bio Organics Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
37.87
Price to Book
0.52
Price to Sales
0.27
PEG Ratio
-0.55
Profitability Ratios
Profit Margin
-0.38%
Operating Margin
-2.08%
Return on Equity
1.45%
Return on Assets
0.61%
Financial Health
Current Ratio
1.14
Debt to Equity
114.89
Beta
0.89
Per Share Data
EPS (TTM)
₹-1.12
Book Value per Share
₹152.40
Revenue per Share
₹285.24
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
dbol | 5.3B | 37.87 | 0.52 | 1.45% | -0.38% | 114.89 |
Venky's (India | 21.3B | 18.28 | 1.44 | 8.20% | 3.53% | 11.50 |
Andrew Yule | 13.0B | 97.44 | 4.76 | -0.84% | -0.91% | 31.10 |
Apex Frozen Foods | 6.9B | 176.91 | 1.39 | 0.78% | 0.48% | 14.69 |
Mishtann Foods | 6.6B | 1.98 | 0.69 | 44.10% | 24.24% | 4.89 |
Mangalam Global | 5.4B | 23.13 | 2.69 | 11.46% | 0.96% | 111.39 |
Financial data is updated regularly. All figures are in the company's reporting currency.